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Abstract: The present study aimed to explore the role of angiotensin-
Receptor-Blocker in the management of anxiety. Male Swiss albino mice 
of age 6-8 weeks and weight 25-30 g were used in the present study. 
Candesartan (angiotensin receptor blocker) was administered in two doses 
(1 and 2 mg/kg; i.p.) to mice for 14 successive days regularly. anxiety 
was induced in mice by two different methods: (i) exposing the mice to 
immobilization stress for a period of 6 h daily for 7 consecutive days; 
(ii) administration of caffeine (25 mg/kg; i.p.) daily for 7 days. elevated 
Zero Maze and Open Field apparatus were used to evaluate the level of 
anxiety in different groups. after behavioral evaluation, the animals were 
sacrificed and their brains were used for estimation TBaRS, GSh and 
Nitrite levels in the brain. administration of Candesartan (1 and 2 mg/kg; 
i.p) for 14 successive days significantly (p<0.05) reduced anxiety due to 
immobilization stress and caffeine induced anxiety. Candesartan (1and 2 
mg/kg; i.p) treated mice showed an increase (p<0.05) in GSh levels while 
a decrease (p<0.05) in TBaRS and nitrite levels in brain. Thus, candesartan 
may prove to be a useful remedy for the management of anxiety owing to 
its neuroprotective and antioxidant activity.
Keywords: angiotensin, Candesartan, anxiety, immobilization stress, 
caffeine
1. INTRODUCTION 
anxiety is an emotional state commonly caused by the perception of real or 
perceived danger which threatens the security of an individual characterized 





disorders may include restlessness, fatigue, mental tension, irritability, sleep 
disturbances, poor stress management, abdominal distress, chest discomfort, 
palpitations, tachycardia, shortness of breath, trembling, blushing, diarrhea, 
sweating, nausea and chills etc. It is the most prominent stress- related 
psychiatric disorder which can produce uncomfortable and potentially 
debilitating psychological feeling of distress. everyone experiences a certain 
amount of nervousness and apprehension when encountered with a stressful 
situation. This is an adaptive response and transient in nature. however, when 
it becomes excessive it may come under the category of a disorder (Saavedra 
et al., 2005). according to recent reports of National institute of Mental 
health (NIMh, USa) lifetime prevalence rate of anxiety affected adults was 
18.1%, out of which 22.8% were severely affected; while lifetime prevalence 
rate for 13 to 18 years old was 25.1%, out of which 5.9% were severely affected. 
Demographic representations for lifetime prevalence show that women are 
60% more likely than men to experience an anxiety disorder. 
higher centers in brain (such as amygdala, hypothalamus and locus 
coeruleus) and abnormal function in neurotransmitter systems (including 
norepinephrine, gamma amino butyric acid and serotonin) are involved in 
the provocation of anxiety (Gabry et al., 2003, Nutt, 2000). Dysregulation of 
the brain noradrenergic system may be a factor in determining vulnerability 
to stress related pathology, as stress activates norepinephrine release in 
a number of stress related limbic regions, such as the central and medial 
amygdala, lateral bed nucleus of the stria terminalis, medial prefrontal cortex, 
and lateral septum (Morilak et al., 2005). Further, serotonin (5-hT) has been 
shown to be involved in a number of pathophysiological processes such as 
depression, hypertension and anxiety (Jenkins, 2008). Furthermore, evidence 
suggests that behavioral indices of anxiety are associated with the promotion 
of dopamine activity within mesolimbocortical and mesolimbic sites. Stimuli 
like mild to moderate stressors activate central dopamine activity, and this 
effect can be prevented by the administration of anxiolytic agents (Ferrer 
et al., 2001). One of the major defining neurobiological features of anxiety 
is hyperactivity of hypothalamo-pituitary-adrenal axis (hPa) with subsequent 
elevation in glucocorticoid levels (released by the adrenal cortex) in response 
to stress. (Burroughs and French, 2007). Therefore, any stressful event leads to 
provocation of anxiety by altering the release pattern of neurotransmitter in the 
brain (Tanaka et al., 2000). Recently, attention has been focused on the role of a 
brain regulatory peptide, angiotensin II. It elicits most of its biological actions 
by binding to specific membrane-bound aT 
1 
receptors on target cells to activate 
multiple intracellular transduction pathways (yin et al., 2003). The brain and 
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which causes stress induced hormone secretion, including CRh, aCTh, 
corticosteroids and vasopressin and in turn stimulates the central sympathetic 
activity (Valdez and Koob., 2003). angiotensin II receptor blockers are 
compounds with a good margin of safety and are widely used in the treatment of 
hypertension. Their anti-inflammatory and vascular protective effects contribute 
to reduce renal and cardiovascular failure (Saavedra et al., 2011). long term 
peripheral administration of angiotensin receptor blocker (candesartan) blocks 
not only peripheral but also brain aT
1 
receptors, preventing the hormonal and 
sympathoadrenal response to stress. Inhibition of brain aT
1
 receptor activity 
may be neuroprotective by reducing exaggerated stress responses and anxiety, 
preventing stress induced gastric ulcerations, decreased vulnerability to ischemia 
and stroke, reversing chronic cerebrovascular inflammation and reduces acute 
inflammatory responses produced by bacterial endotoxin (Benicky et al., 2009). 
These effects may protect neurons from injury and contribute to increased life 
span. Inhibition of brain aT
1
 receptors in humans is also reported to reduce 
the incidence of stroke, improving cognition and decrease the progression of 
alzheimer’s disease (Saavedra et al., 2011).
anxiolytic effects of the angiotensin II aT
1 
receptor antagonist losartan were 
studied in the elevated plus maze and light/dark test in different mouse strains 
(Gard et al., 2001). Blockade of aT
1
 receptors offers a novel and safe therapeutic 
approach for the treatment of illnesses of increasing prevalence and socioeconomic 
impact, such as anxiety disorders and other neurodegenerative diseases of the 
brain. however, the literature reports regarding the role of angiotensin receptor 
blocker is limited. Therefore, the present study was undertaken to explore the 
potential of candesartan (an angiotensin receptor blocker) in the management of 
anxiety using stress induced and caffeine induced anxiety models.
2. MATERIALS & METHODS
2.1 Drugs & Chemicals
Candesartan and alprazolam were purchased from Sigma aldrich (China). 
Caffeine and thiobarbituric acid, 5,5-Dithiobis (2-nitrobenzoic acid) were 
procured from himedia laboratories, Mumbai. Reduced glutathione from 
SRl, Mumbai. all the other chemicals were of analytical grade.
2.2 Animals
Male Swiss mice weighing between 22-30 g were procured from Disease 
free small animal house, lala lajpat Rai University of Veterinary and 
animal Sciences, hisar. The experimental protocols were approved by the 





under standard laboratory conditions with controlled temperature (23 ± 2°C), 
humidity (40 ± 10%) and 12 h light and dark cycles each. The animals were 
fed with standard rodent pellet diet (ashirwad Industries, Mohali) and water 
ad libitum. The experiments were carried out between 09.00 and 17.00 h. 
The laboratory animals were maintained as per the guidelines of CPCSea, 
Ministry of environment and Forests, Government of India.
2.3 Induction of Anxiety
anxiety was induced in animals experimentally by following two methods:
 (a)  Immobilization Stress: animals were subjected to immobilization stress 
of 6 hours daily for 7 consecutive days to both stressed and drug treated 
groups. each mouse was gently handled and immobilized individually 
with their ventral body facing the platform in 50 ml centrifuge tubes 
with two holes at both the ends so that the animal can properly respire 
and their tails were kept outside the tubes through rear hole and secured 
with adhesive tape to the surface so that the animals cannot move at all. 
The experiments were conducted at fixed time of the day through-out 
the observation (Sur and Bhattacharya, 1997 & Dhir et al., 2006).
 (b)  Caffeine induced anxiety: administration of Caffeine (25 mg/kg; i.p.) 
to mouse for 7 days daily induces anxiety (Oh ki-wan et al., 2010). 
2.4 Experimental Design
The animals were divided into different groups (n=6). Candesartan was 
administered daily by intraperitoneal injection to mice for 14 successive days 
at two doses i.e. 1 and 2 mg/kg. The doses of candesartan were selected on 
the basis of literature reports (Sanchez-lemus et al., 2012). In immobilization 
stress model, the animals were subjected to 6 hours of immobilization for 7 
successive days, starting from 8th day of candesartan administration upto 14th day. 
In caffeine-induced anxiety model, caffeine (25 mg/kg; i.p.) was administered 
for 7 successive days starting from 8th day of candesartan administration upto 
14th day. On 15th day, the animals were subjected to behavioural assessment 
using elevated Zero Maze test and Open Field test. alprazolam served as 
standard drug to compare the putative outcomes of candesartan treatment and 
was administered intraperitoneally for 14 successive days to mice at a dose of 
0.25 mg/kg (Nunez et al., 2011). after behavioral evaluation, the animals were 
sacrificed and brains were used for estimations of thiobarbituric acid reactive 
substances (TBaRS; by method of Ohkawa et al., 1979), reduced glutathione 
(GSh; by method of ellman et al., 1959) and Nitrite (by method of Green 
et al., 1982) levels. The results were statistically analyzed by one-way aNOVa 
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2.5 Elevated Zero Maze Test
The elevated zero maze (eZM) is a sensitive behavioral test that reveals animals 
neophobia or anxiety and can be used to unveil antineophobic and anxiolytic 
actions of drugs. This maze is an elevated (40 cm) black, annular having outer 
diameter of 45 cm and inner diameter of 30 cm. The runway ring where the 
mouse can explore is of 6 cm width, which is divided into 4 quadrants, 2 opposing 
“open” quadrants without walls and 2 opposing “closed” quadrants having 12 cm 
high walls. The open quadrants have a ridge of 2-3mm to prevent the mouse to 
fall off. The walls have thickness of 0.75 cm. animals were individually placed 
in closed arm facing towards the open arm and the following parameters were 
noted for a period of five minutes (Shepherd et al., 1994; Braun et al., 2011). 
 a)  latency to enter the open arm (leO): The time gap between the 
first entry of animal in open arm after placing it in the closed arm. 
enhancement of leO as compared to control group indicates induction 
of anxiety and vice-versa.
 b)  Time spent in open arm (TSO): It is the time spent by the animal 
in open arm out of total allotted 5 min. Reduction of TSO indicates 
induction of anxiety and vice-versa.
 c)  Number of entries in the open arm (NeO): It is the frequency of entry 
of animal in the open arm. higher the frequency of entry in open arm 
lower is the level of anxiety.
2.6 Open Field test
This behavioral model is based on the induction of anxiety state such as 
ambulation or freezing by exposing animals to a highly novel field environment. 
an open field apparatus consists of a circular arena (wall height 27 cm; 
diameter 84 cm) with 25 houses. animals were placed in circular open arena of 
apparatus. When animal moves from one segment to another, one ambulation 
(simple stereotypy) was recorded. Similarly when the animal stands on its hind 
limbs, one rearing (complex stereotypy) was recorded. anxiolytic drug action 
was reflected by increased central and peripheral ambulation and rearing with 
decreased fecal boli, grooming and freezing time, in comparison to normal 
control groups (Kulkarni & Dandiya, 1974).
3. RESULTS
3.1 Effect of candesartan on LEO in elevated zero maze:
Mice exposed to immobilization stress for 6 h for seven consecutive days 





normal control mice. however, mice pretreated with candesartan (1 or 2 mg/kg; 
i.p.) for 14 days prevented the rise in leO significantly (p<0.05) as compared 
to stress control group. alprazolam (0.25 mg/kg; i.p.) pretreatment for 14 days 
also reduced (p<0.05) the latency when compared with stress control group. 
administration of caffeine (25 mg/kg; i.p.) to mice caused increase in leO 
(p<0.05) in caffeine control group as compared to normal control. Pretreatment 
of mice with candesartan for 14 days reduced (p<0.05) the leO as compared 
to caffeine control group. alprazolam pretreatment for 14 days also reduced 
(p<0.05) the latency when compared with caffeine control group (Figure 1).
3.2 Effect of candesartan on NEO in elevated zero maze
exposure of mice to immobilization stress for 6 h daily for 7 successive 
days markedly reduced (p<0.05) NeO in stress control group as compared 
to normal control mice. Pretreatment with candesartan (1 or 2 mg/kg; i.p.) 
for 14 days increased the NeO significantly (p<0.05) as compared to stress 
control group. alprazolam pretreatment for 14 days also increased (p<0.05) 
the NeD as compared with stress control group. animals treated with caffeine 
(25 mg/kg; i.p.) showed decreased (p<0.05) NeO in caffeine control group as 
compared to normal control mice. Pretreatment with candesartan for 14 days 
increased NeO significantly (p<0.05) as compared to caffeine control group. 
alprazolam pretreatment for 14 days also increased (p<0.05) the number of 
entries when compared with caffeine control group (Figure 2). 
Figure 1: effect of Candesartan on latency to enter the open arm (leO) in 
elevated zero maze. 
Values are expressed as mean ± S.e.M. a-p<0.05 vs normal control; b- p<0.05 vs 
stress control; c- p<0.05 vs caffeine control. aRB1= Candesartan 1mg/kg, aRB2 = 
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Figure 2: effect of Candesartan on Number of entries in the open arm (NeO) 
in elevated zero maze. 
Values are expressed as mean ± S.e.M. a-p<0.05 vs normal control; b- p<0.05 vs 
stress control; c- p<0.05 vs caffeine control. aRB1= Candesartan 1mg/kg, aRB2 = 
Candesartan 2 mg/kg and aPZ = alprazolam 0.25 mg/kg.
Figure 3: effect of Candesartan on time spent in the open arm (TSO) in 
elevated zero maze. 
Values are expressed as mean ± S.e.M. a-p<0.05 vs normal control; b- p<0.05 vs 
stress control; c- p<0.05 vs caffeine control. aRB1= Candesartan 1mg/kg, aRB2 = 





3.3 Effect of candesartan on TSO in elevated zero maze
exposure to immobilization stress showed a decrease (p<0.05) in TSO in 
stress control group as compared to normal control mice. Pretreatment with 
candesartan (1 & 2 mg/kg; i.p.) for 14 days increased the TSO significantly 
(p<0.05) as compared to stress control group. alprazolam pretreatment for 
14 days also increased (p<0.05) the TSO when compared with stress control 
group. animals treated with caffeine (25 mg/kg; i.p.) showed a decrease 
(p<0.05) in TSO in caffeine control group as compared to normal control. 
Pretreatment with candesartan for 14 days increased the TSO significantly 
(p<0.05) as compared to caffeine control group. alprazolam pretreatment for 
14 days also increased (p<0.05) the TSO when compared with caffeine control 
group (Figure 3). 
3.4 Effect of candesartan on ambulation behavior of mice in open field
exposure to immobilization stress showed a decrease (p<0.05) in ambulation 
in stress control group as compared to normal control mice. Pretreatment 
with candesartan for 14 days increased the ambulation significantly (p<0.05) 
as compared to stress control group. alprazolam pretreatment for 14 days 
also increased (p<0.05) the ambulation when compared with stress control 
group. animals treated with caffeine (25 mg/kg; i.p.) showed decreased 
(p<0.05) ambulation in caffeine control group as compared to normal control. 
Pretreatment with candesartan for 14 days increased the ambulation significantly 
(p<0.05) as compared to caffeine control group. alprazolam pretreatment for 
14 days also increased (p<0.05) the ambulation when compared with caffeine 
control group (Table 1).
3.5 Effect of candesartan on rearing behavior of mice in open field
exposure to immobilization stress showed a decrease (p<0.05) in rearing in 
stress control group as compared to normal control mice. Pretreatment with 
candesartan (1 & 2 mg/kg; i.p.) for 14 days increased the rearing significantly 
(p<0.05) as compared to stress control group. alprazolam pretreatment for 14 
days also increased (p<0.05) the rearing when compared with stress control 
group. animals treated with caffeine (25 mg/kg; i.p.) showed decreased 
(p<0.05) rearing in caffeine control group as compared to normal control. 
Pretreatment with candesartan (1 & 2 mg/kg; i.p.) for 14 days increased 
the rearing significantly (p<0.05) as compared to caffeine control group. 
alprazolam pretreatment for 14 days also increased (p<0.05) the rearing when 
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3.6 Effect of candesartan on biochemical parameters
The animals exposed to immobilization stress showed higher brain TBaRS 
and nitrite level (p<0.05) as compared to normal control mice, however GSh 
Table 1: effect of Candesartan on ambulation and rearing score using open 
field test.
Group ambulation score Rearing score
Normal control 75.16 ± 7.46 5.5 ± 0.42
Stress control 59.83 ± 2.37a 3.0 ± 0.36a
Stress + aRB1 103.55 ± 1.78b 113.66 ± 0.55b
Stress + aRB2 110.68 ± 2.09b 14.16 ± 0.7b
Stress + alprazolam 139 ± 4.68b 21.66 ± 0.98b
Caffeine control 50.16 ± 3.17a 3.16 ± 0.47a
Caffeine + aRB1 97.5 ± 1.97c 12.16 ± 0.79c
Caffeine + aRB2 102.5 ± 2.81c 12.33 ± 0.8c
Caffeine + alprazolam 145.5 ± 2.07c 22.16 ± 1.16c
Values are expressed as mean ± S.e.M. a-p<0.05 vs normal control; b- p<0.05 vs 
stress control; c- p<0.05 vs caffeine control. aRB1= Candesartan 1mg/kg, aRB2 = 
Candesartan 2 mg/kg and aPZ = alprazolam 0.25 mg/kg.
Table 2: effect of Candesartan on biochemical parameters.
Group TBaRS GSh Nitrite
Normal control 0.3 ± 0.007 2.35 ± 0.13 5.33 ± 0.25
Stress control 0.73 ± 0.008a 1.23 ± 0.4a 11.44 ± 0.1a
Stress + aRB1 0.61 ± 0.007b 1.58 ± 0.1b 8.25 ± 0.07b
Stress + aRB2 0.52 ± 0.007b 1.71 ± 0.02b 7.52 ± 0.15b
Stress + alprazolam 0.42 ± 0.007b 1.89 ± 0.01b 7.18 ± 0.08b
Caffeine control 0.74± 0.007a 1.4 ± 0.07a 11.47 ± 0.4a
Caffeine + aRB1 0.63± 0.006c 1.7 ± 0.03c 8.42 ± 0.07c
Caffeine + aRB2 0.54± 0.007c 1.75 ± 0.02c 7.67 ± 0.3c
Caffeine + alprazolam 0.43± 0.007c 1.89 ± 0.04c 7.34 ± 0.34c
Values are expressed as mean ± S.e.M. a- p<0.05 vs normal control; b- p<0.05 vs 
stress control; c- p<0.05 vs caffeine control. aRB1= Candesartan 1mg/kg, aRB2 = 





levels were reduced. Pretreatment with candesartan (1 & 2 mg/kg; i.p.) for 14 
days not prevented the stress-induced rise in brain TBaRS as well as nitrite 
level (p<0.05) but also prevented the reduction of GSh levels as compared 
to stress control group. alprazolam pretreatment for 14 days also (p<0.05) 
prevented the stress-induced oxidative damage as expected. The animals treated 
with caffeine also showed higher brain TBaRS and nitrite levels (p<0.05) as 
compared to normal control mice. Pretreatment with candesartan (1 & 2 mg/
kg; i.p.) for 14 days prevented the caffeine-induced rise in brain TBaRS / 
nitrite level (p<0.05) and fall in GSh levels as compared to caffeine control 
group (Table 2)
4. DISCUSSION
The present study investigates the probable role of angiotensin receptor 
blocker (candesartan) in relieving anxiety in rodents. The result of elevated 
zero maze describes a possible anxiolytic effect of candesartan as shown by 
the increased number of entries arm and enhancement in total time spent 
in open arm in immobilization as well as caffeine-induced anxiety groups. 
The same pattern of results was observed in open field test. Immobilization 
stress is a useful tool to induce anxiety in rodents by immobilizing the 
animal through physical means. This model combines emotional stress 
(escape reaction) and physiological stress (muscle work), resulting in 
both restricted mobility and aggression (Saavedra et al., 2012; Dhir et al., 
2006). Caffeine exerts dose related effect on rodents, showing locomotor 
stimulation at lower dose while anxiogenic like effects at higher dose. at 
higher dose caffeine increases GaBa
a 
receptor expression in cerebro-cortical 
membranes (Jain et al., 2005; Oh Ki-wan et al., 2010). In the present study, 
a significant rise in anxiety was observed in immobilization stress-induced 
and caffeine-induced anxiety groups as compared to control animals. as 
a stress hormone, norepinephrine affects the parts of the brain such as 
amygdala which plays a key role in the regulation of stress (Saavedra et al., 
2011). Gelband et al., 1997 states that neuronal aT
1
 receptors are localized 
on the plasma membrane of neuronal cell soma and the hypothalamus and 
brainstem nuclei contain high concentrations of angiotensin receptors and 
their stimulation results in profound effects on catecholamine turnover. 
Many types of physical stress such as immobilization stress or restraint 
stress increases brain angiotensin II formation and upregulates the aT
1 
receptors within the blood brain barrier specifically in hPa axis which 
contributes to the stimulation of stress pathways in the brain (Quirin et al., 
2008). This stimulation of brain angiotensin II activity ultimately results 










receptor activation alters norepinephrine uptake, synthesis, and 
release from hypothalamus brainstem neuronal cells (Saavedra & Benicky, 
2007). Therefore, it is suggested that norepinephrine has implications in 
stress induced anxiety. Caffeine at higher dose increases the rate of synthesis 
and turnover of norepinephrine. however, the mechanism by which caffeine 
activates the noradrenaline neurons is not known (Nutt, 1990). Therefore, 
it is quite possible that the observed anxiolytic effect of candesartan may 
be by virtue of affecting norepinephrine levels through aT
1
 receptors. 
Furthermore, it is also proposed by previous reports that administration 
of candesartan may relieve anxiety by modulating norepinephrine levels 
(Saavedra et al; 2005 & 2011). 
In the present study, we report the antioxidant property of candesartan 
as demonstrated by reduction in brain TBaRS as well as Nitrite levels 
and enhancement in reduced GSh levels after administration for 14 days 
to stressed animals. Stress causes enhancement of oxidative damage and 
results in enhancement of lipid peroxidation and reduced antioxidant 
defense (li et al., 2013). In the present study, animals subjected to both 
immobilization stress and caffeine induced anxiety exhibited an increase in 
brain TBaRS levels and decrease in GSh levels. Stress causes oxidative 
injury and malondialdehyde (MDa) is one of several low-molecular-weight 
end products formed via the decomposition of certain primary and secondary 
lipid peroxidation product. MDa readily participates in nucleophilic addition 
reaction with 2-thiobarbituric acid (TBa), generating thiobarbituric acid 
reactive substances, which is an indicator of increased lipid peroxidation 
(Janero, 1990). however, glutathione is a ubiquitous thiol-containing 
tripeptide that is produced in all organs and it is implicated in the cellular 
defense against xenobiotics and naturally occurring deleterious compounds, 
such as free radicals and hydroperoxides. Glutathione not only protects cell 
membranes from oxidative damage, but also helps to maintain the sulfhydryl 
groups of many proteins in the reduced form, a requirement for their normal 
function (Trachootham et al., 2007).
It is worthwhile to mention here that angiotensin receptor blockers are 
mainstay of antihypertensive therapy. The rise in blood pressure is one of 
the symptoms and hallmark of anxiety associated disorder. The possibility 
that the decrease in blood pressure by administration of candesartan may be 
contributing to relieve the anxiety in mice, cannot be ruled out. however, 
the dose of candesartan required for eliciting antihypertensive activity and 
anxiolytic activity may be an intercept. In spite of all this discussion, further 
investigations are very much warranted to consolidate the potential of 
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